Background {#Sec1}
==========

Growth of new tissue and scar formation are two important issues in tissue injury. Fibroblasts are the main cells in the wound healing process because they migrate and proliferate to the injury site after 2 or 3 days. Then, the cells produce extracellular matrix especially collagen. Growth factors play important roles in the proliferation, migration, and production of ECM substances by fibroblasts. Recently, researches showed that the growth factor TGF-β has an important role in the process not only in wound healing but also in scar formation. TGF-β applies their effects via the intracellular SMAD pathway. \[[@CR1], [@CR2]\]. It has been shown that TGFβ1 activates angiogenesis by stimulating vascular smooth muscle cell migration \[[@CR3]--[@CR5]\]. The importance of this factor in creating and maintaining the vascular system has been proved by numerous studies. TGFβ1 and its receptors lead to fetal death due to impaired vessel formation \[[@CR6], [@CR7]\]. TGFβ1 induces the maturation of retinoic acid-inducible gene I (RIGI), therefore, stimulates the formation and intensification of interaction between epithelial cells and the basement membrane of the mural cells \[[@CR8]--[@CR10]\]. Also bFGF, (FGF 2 or FGF-β) contribute to control of endothelial cells and fibroblasts migration, which are responsible for angiogenesis and collagen formation of the epithelial layer \[[@CR1], [@CR9], [@CR11]\].

*Calendula officinalis* L. (Asteraceae) has been traditionally used in the treatment of various diseases such as skin tumors, dermatological lesions, and swellings. Despite a long tradition of use of *Calendula officinalis* L., the biological aspect of its activity has not been explored properly. Recent research supports the medicinal potential of *Calendula officinalis* L. *Calendula officinalis* L. properties need to be investigated to determine their varied biological activities and mechanism of actions. To determine the effectiveness of the *Calendula officinalis* L. in the treatment of dermatologic disorders, more research is necessary to understand the action mechanism of this plant. Therefore, the aim of this study is to determine the effect of the *Calendula officinalis* L. extract on proliferation and expression of two important growth factors, TGFβ1 and bFGF, at the MEFs.

Materials and methods {#Sec2}
=====================

Preparation of *Calendula officinalis* extract {#Sec3}
----------------------------------------------

Twenty grams of dried flowers of *Calendula officinalis* were collected from Lorestan Agricultural and Natural Resources Research and Education Center and soaked in 120 ml of 50% ethanol or methanol for 72 h in a dark. In the next step, it was centrifuged and passed through the filter and dried at room temperature to yield 8.7% *w*/*w* extract. Then the extract was stored at − 20 °C until further use.

GC-MS analysis of *Calendula officinalis* extract {#Sec4}
-------------------------------------------------

Different substances within *Calendula officinalis* extract defined with gas chromatography and mass spectrometry (GC-MS) at the Lorestan University.

Isolation and culture of MEFs {#Sec5}
-----------------------------

Isolation and culture of mouse embryonic fibroblasts (MEFs) were performed according to the protocol described elsewhere \[[@CR12]\]. In the brief, a pregnant mouse at 13 or 14 days post-coitum (d.p.c) was sacrificed by dislocating of cervical vertebrae and uterine horns were dissected and rinsed in 70% (*v*/*v*) ethanol and placed into a Falcon tube with PBS buffer, without calcium and magnesium ions. The embryos were separated from its embryonic sac and placenta. Then, 1 ml of 0.05% trypsin/EDTA (Gibco, Invitrogen) containing 100 K units of DNase I per each embryo was added and incubated at the room temperature for 15 min. Cells were dissociated by pipetting each 5 min. Trypsin inactivated by the addition of 1 volume of freshly prepared MEF medium. Then, cells were centrifuged and the cell pellet was washed in warm MEF medium.

MTT assay {#Sec6}
---------

To evaluate cell viability, fibroblast cells incubated with different concentrations of *Calendula officinalis* (5 μg/ml, 10 μg/ml, 20 μg/ml, 40 μg/ml, and 50 μg/ml) for 12, 24, 48, and 72 h. Then, 20 μl of MTT (5 mg/ml, Sigma) in PBS solution added into each of the wells, and the plate was further incubated for 4 h. In the next step, 200 μl of DMSO added into each well, incubated for 15 min to dissolve the formed crystal formation and the light absorption measured using an enzyme-linked immunosorbent assay (ELISA) reader. Cell viability expressed as a percentage of absorbance values in treating cells.

Analysis of TGF β 1 and bFGF gene expression by real-time PCR {#Sec7}
-------------------------------------------------------------

MEFs were exposed to different concentrations of ethanolic and methanolic *Calendula officinalis* extracts (5 μg/ml and 10 μg/ml) and then, cells were collected at 12 and 24 h using trypsin/EDTA. Total RNA isolated and the concentration and purity of RNA determined using biophotometer (Eppendorf, Hamburg, Germany). The concentration and quality of the RNA samples confirmed by electrophoresis on 1% denatured agarose gel.

Following procedures were performed:Generation of first strand cDNA with 1 μg total RNA using the cDNA Synthesis Kit (Roche Diagnostics GmbH, Mannheim, Germany).Selection of HPRT as the housekeeping gene.Real-time quantitative PCR by using Rotor-Gene 6000 and SYBR-Green quantitative PCR (qPCR) kit (Jena Bioscience, Cat No. 311S)

Oligonucleotide sequences of the primers and their characteristics are presented in Table [1](#Tab1){ref-type="table"}.Table 1Sequences of primers for real-time quantitative PCRGenePrimerProduct sizeTmHPRTSense:CCTCCTCAGACCGCTTTTT9179.5Antisense:AACCTGGTTCATCATCGCTAAFGF2Sense: AACGGCGGCTTCTTCCTG13378.9Antisense:TGGCACACACTCCCTTGATAGTGFβ1Sense: ATTCCTGGCGTTACCTTGG11776.9Antisense:CCTGTATTCCGTCTCCTTGG

Analysis of TGFβ1 and bFGF protein expression by ELISA {#Sec8}
------------------------------------------------------

MEFs were cultured in 6-well plates (10^5^ cell per well) and were exposed to ethanolic and methanolic extract of *Calendula officinalis* (5 μg/ml, 10 μg/ml) and supernatant were collected at 12 and 24 h. Samples were frozen at − 20 °C. TGF-β1 protein concentration in cell culture supernatants was measured by Ready-Set-GO TGF-β1 cytokine ELISA kit from eBioscience (San Diego, CA, USA, Catalog Number: 88-8350) and FGF ELISA kit (Cat no. ELH-bFGF-001; RayBiotech, Inc., St. Louis, MO).

Statistical analysis {#Sec9}
--------------------

The statistical analysis of data was done by using SPSS software. Differences between the groups were analyzed by using Wilcoxon test. Differences were considered significant at (*P* \< 0.05).

Results {#Sec10}
=======

GC-MS analysis {#Sec11}
--------------

GC-MS analysis showed that the main components present in the *Calendula officinalis* extract are carvacrol, thymol, ethyl hexadecanoate, and viridiflorene (Table [2](#Tab2){ref-type="table"}).Table 2GC-MS analysis showed that the main components present in the *Calendula officinalis* extract are carvacrol, thymol, ethyl hexadecanoate, and viridiflorenet'R(A)RI(Calc)RI(STD)SimilarityCompound nameArea (%)4.092832.571428680083%Hexanal1.0059614.23384683095%Furfural1.4157974.375859.523809585192%Furfuryl alcohol1.4530554.958910.533333389980%Heptanal1.192255.267931.133333399881%Octanal1.2543475.933975.533333395794%Furfural 5-methyl1.204676.175991.666666791180%Amyl acetate3.5519136.5171010.43269295093%Glycerin19.547947.5921062.115385111280%Heptyl acetate2.7074028.0921086.153846110677%Maltol1.80079510.7671185.402504117170%Umbellulone0.38499812.21230.191458122885%Citronellol1.47789414.4331295.964654128580%Bornyl acetate0.47193214.6421301.899736129093%Thymol1.32886214.9671310.474934129895%Carvacrol7.1907619.6581432.944162143982%Aromadendrene0.42225520.5171454.746193145887%Beta Farnesene0.98112322.1921497.258883146783%Caryophyllene0.69547922.4671504.249364149393%Viridiflorene3.15449623.4331528.829517152491%Delta Cadinene1.04321924.7081561.272265154990%Elemol0.3477426.1421597.760814160090%Hexadecane0.47193229.1251674.806202165880%Eudesmol2.30998529.2751678.682171169180%Juniper Camphor0.47193229.9921697.209302170087%Heptadecane0.39741739.6751967.424242195990%Hexadecanoic acid0.89418840.6331996.454545199393%Ethyl hexadecanoate0.558867

Effect of *Calendula officinalis* extract on MEFs viability {#Sec12}
-----------------------------------------------------------

The results of MTT assay to determine if *Calendula officinalis* ethanolic/methanolic extract affects cell viability of MEFs at different concentration (5 μg/ml, 10 μg/ml, 20 μg/ml, 40 μg/ml) showed that the *Calendula officinalis* extract using both solvents was non-toxic to the cells. The concentrations of 5 μg/ml and10 μg/ml were more suitable for cell proliferation. Therefore, this study was evaluated in these concentrations (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Effect of ethanolic (**a**) and methanolic (**b**) extract of Calendula on MEFs viability. Cells were treated with different concentration of Calendula for 12, 24, 48, and 72 h and cell viability was measured by MTT assay

TGF β 1 and bFGF gene expression {#Sec13}
--------------------------------

Analysis of *TGF* β *1* gene expression for the ethanolic extract (Fig. [2](#Fig2){ref-type="fig"}a) and the methanolic extract (Fig. [2](#Fig2){ref-type="fig"}b), revealed an increase *TGF* β *1* gene expression in the MEFs at different concentrations (5 μg/ml, 10 μg/ml) at 12 h after treatment (*P* \< 0.05 and *P* \< 0.01 respectively). But the expression of *TGF* β *1* gene remained the same 24 h at the two concentrations after treatment with ethanolic extract (Fig. [2](#Fig2){ref-type="fig"}a and Table [3](#Tab3){ref-type="table"}). The methanolic extract results revealed an increase in the expression for the two extracts at 12 h and a decline in the expression of the gene at 24 h (Fig. [2](#Fig2){ref-type="fig"}b and Table [4](#Tab4){ref-type="table"}) (*P* \< 0.05 and *P* \< 0.01 respectively). Gene expression of *bFGF* in the MEFs indicated a similar pattern with *TGF* β *1* expression for both solvent, an increase *bFGF* gene expression in the MEFs at different concentrations (5 μg/ml, 10 μg/ml) at 12 h after treatment (*P* \< 0.05 and *P* \< 0.01 respectively). But the expression of *bFGF* gene remained the same 24 h at the two concentrations after treatment with ethanolic extract (Fig. [3](#Fig3){ref-type="fig"}a and Table [5](#Tab5){ref-type="table"}). The methanolic extract results indicated an increase in the expression for the two extracts at 12 h and a decline in the expression of the gene at 24 h (Fig. [3](#Fig3){ref-type="fig"}b and Table [6](#Tab6){ref-type="table"}) (*P* \< 0.05 and *P* \< 0.01 respectively) (Table [2](#Tab2){ref-type="table"}).Fig. 2Relative expression of *TGF* β *1* gene in the MEFs that were treated with various concentrations of ethanol (**a**) and methanol (**b**) extracts of Calendula at different time intervals treatment (12 and 24 h). All comparisons were made compared to the control group. \**P* \< 0.05, \*\**P* \< 0.01. Abs gene reg: Absolute gene regulationTable 3The total expression ratio of the gene of *TGF*β*1* in the MEFs treated with various concentrations of ethanol extract of Calendula (5 and 10 μg/ml) relative to control group is presented in each time (12 and 24 h after treatment). The statistic test for significance is randomization re-allocation test, implemented in the relative expression software tool. Significant down or upregulations of the genes highlighted12 h after treatment24 h after treatment5 μg/ml10 μg/ml5 μg/ml10 μg/mlRelative expression1.72.30.70.62Standard error± 0.21± 0.28± 0.24± 0.16*P* value0.2350.0010.4900.359Fold increase/decrease+ 1.7+ 2.3− 1.4− 1.6Table 4The total expression ratio of the gene of *TGF*β*1* in the MEFs treated with various concentrations of methanol extract of Calendula (5 and 10 μg/ml) relative to control group is presented in each time (12 and 24 h after treatment). The statistic test for significance is randomization re-allocation test, implemented in the relative expression software tool. Significant down or upregulations of the genes highlighted12 h after treatment24 h after treatment5 μg/ml10 μg/ml5 μg/ml10 μg/mlRelative expression1.32.10.70.62Standard error± 0.23± 0.24± 0.2± 0.13*P* value0.2650.0010.6610.001Fold increase/decrease+ 1.3+ 2.1− 1.06− 2.5Fig. 3Relative expression of *bFGF* gene in the MEFs that were treated with various concentrations of ethanol (**a**) and methanol (**b**) extracts of Calendula at different time intervals treatment (12 and 24 h). All comparisons were made compared to the control group. ٭*P* \< 0.05, ٭٭*P* \< 0.01. Abs gene reg: Absolute gene regulationTable 5The total expression ratio of the gene of *bFGF* in the MEFs treated with various concentration of ethanol extract of Calendula (5 and 10 μg/ml) relative to control group is presented in each time (12 and 24 h after treatment). The statistic test for significance is randomization re-allocation test, implemented in the relative expression software tool. Significant down or upregulations of the genes highlighted12 h after treatment24 h after treatment5 μg/ml10 μg/ml5 μg/ml10 μg/mlRelative expression1.92.20.420.39Standard error±0.24±0.29±0.19±0.18P- value0.2560.0010.0010.001Fold increase/decrease+ 1.9+ 2.2− 2.4−2.5Table 6The total expression ratio of the gene of *bFGF* in the MEFs treated with various concentration of methanol extract of Calendula (5 and 10 μg/ml) relative to control group is presented in each time (12 and 24 h after treatment). The statistic test for significance is randomization re-allocation test, implemented in the relative expression software tool. Significant down or upregulations of the genes highlighted12 h after treatment24 h after treatment5 μg/ml10 μg/ml5 μg/ml10 μg/mlRelative expression1.52.10.520.34Standard error± 0.25± 0.27± 0.17± 0.19*P* value0.2310.0010..2750.001Fold increase/decrease+ 1.5+ 2.1− 1.9− 2.96

TGFβ1 and bFGF protein expression {#Sec14}
---------------------------------

Analysis of TGFβ1 protein expression of the ethanolic extract (Fig. [4](#Fig4){ref-type="fig"}a) and the methanolic extract (Fig. [4](#Fig4){ref-type="fig"}b) revealed an increase TGFβ1 gene expression in the MEFs at different concentrations (5 μg/ml, 10 μg/ml) at 12 h (*P* \< 0.05 and *P* \< 0.01 respectively). But the expression of TGFβ1 protein was slightly reduced, 24 h at the two concentrations after treatment with ethanolic extract (Fig. [4](#Fig4){ref-type="fig"}a). The methanolic extract results indicated a similar pattern (Fig. [4](#Fig4){ref-type="fig"}b) (*P* \< 0.05 and *P* \< 0.01 respectively).Fig. 4Effect of various concentrations of ethanol (**a**) and methanol (**b**) extracts of Calendula the expression of TGFβ1 protein in the MEFs culture supernatants. The MEFs were treated with different concentration of ethanol and methanol extracts of Calendula (5 and 10 μg/ml) at different time intervals treatment (12 and 24 h) and the expression of TGFβ1 protein was assessed by ELISA

Protein expression of bFGF in MEFs revealed an increase in bFGF protein expression at different concentrations (5 μg/ml, 10 μg/ml) of 12 h after treatment (*P* \< 0.05 and *P* \< 0.01 respectively). The same increasing pattern of bFGF protein expression was observed 24 h at the two concentrations after treatment with ethanolic extract. The methanolic extract results indicated a similar pattern with that of the ethanolic extract, as compared with the control (*P* \< 0.05 and *P* \< 0.01 respectively).

When the ethanolic and methanolic extracts of *Calendula officinalis* were compared, ethanolic extract indicated more effective to stimulate MEFs (Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, and [4](#Fig4){ref-type="fig"} and Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"}, and [6](#Tab6){ref-type="table"}).

Discussion {#Sec15}
==========

The results of the present study indicated that both methanol and ethanol extracts of *Calendula officinalis* had non-toxic effects of different concentration. The extracts similar to previous studies increased proliferation of the MEFs \[[@CR13], [@CR14]\]. Among different concentrations of Calendula extraction 5 and 10 μg/ml were more suitable for cell proliferation.

Previous investigation revealed that *Calendula officinalis* can inhibit collagen degradation and matrix metalloproteinase (MMP) activity, and induce neovascularization in the chorioallantoic membrane and skin wound.

Quercetin, one of the active components in Calendula, can decrease the expression of tumor necrosis factor-α (TNF-α), interleukin-1β, IL-6, and IL-8 \[[@CR14]--[@CR17]\].

During the wound healing process, fibroblasts play a crucial role. Then, the cells proliferate and migrate into the wound area, synthesis extracellular matrix (EXM), and the express of thick actin bundles as myofibroblasts \[[@CR18], [@CR19]\].

Important cytokines that produce by fibroblast are TGFβ1 and bFGF. TGFβ1 and bFGF impacts on cell division, cell migration, cell differentiation, protein expression, and enzyme production and have the potential ability to heal wounds through stimulation of angiogenesis factors and cellular proliferation which affects the ECM production and degradation through their chemotactic role on inflammatory cells and fibroblasts \[[@CR20]\].

Several studies indicated that upregulation of TGFβ1 can stimulate the production of fibrotic disease \[[@CR21], [@CR22]\].

In the present study, *Calendula officinalis* increased TGFβ1 and bFGF at the first 12 h therefore stimulate wound healing. Then, the decrease of these factors at 24 h suppressed the expression of TGFβ1 and bFGF and may inhibit the fibrotic process. The Calendula at first may upregulate the expression of TGFβ1 and bFGF but after that may downregulate the expression of these genes.

Conclusion {#Sec16}
==========

*Calendula officinalis* not only shows no cytotoxicity effects on MEFs but also stimulates proliferation of these cells. Calendula via increased expression of growth factors (TGFβ1 and bFGF) at the first 12 h, and a decrease of these factors at 24 h after treatment may ameliorate function of fibroblasts in the during wound healing.
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